Loading clinical trials...
Loading clinical trials...
Study of the Benefit of Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma (HCC)
Conditions
Interventions
Lenvatinib
Locations
6
France
Hospital Haut levêque
Bordeaux, France
Hospital Henri Mondor
Créteil, France
Hospital Claude Huriez
Lille, France
Pontchaillou Hospital
Rennes, France
Hospital Trousseau
Tours, France
Paul Brousse Hospital
Villejuif, France
Start Date
July 10, 2024
Primary Completion Date
April 1, 2027
Completion Date
April 1, 2027
Last Updated
April 7, 2025
NCT06707233
NCT05911633
NCT06187961
NCT06561399
NCT04224636
NCT06397222
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions